Biocrucible, a Sapphiros Company, Appoints Per Grufman as CEO

CAMBRIDGE, U.K., Jan. 20, 2023 /PRNewswire/ — Biocrucible, a Sapphiros platform company dedicated to building the next generation of consumer diagnostics, announced the appointment of Per Grufman, Ph.D., as its Chief Executive Officer. A biotech industry veteran of thirty years, Dr. Grufman will lead the development and commercialization of Biocrucible’s isothermal amplification technologies for next-generation […]